Wharton's Jelly and Exosome Supplier for Pain Clinics in Oklahoma City

What pain practices typically ask for before stocking a lot

Pain management groups evaluating a Wharton's jelly or exosome supplier generally request the same core set of records: a certificate of analysis for the specific lot, a donor eligibility summary, and a description of how the product was processed and screened.

For exosome products specifically, practices often also ask for the available characterization data — particle concentration, marker identification and the growth-factor panel reported by the supplier — so their own regulatory review has something concrete to evaluate against section 351 of the Public Health Service Act.

• Certificate of analysis for the lot
• Donor eligibility summary
• Processing and screening description
• Available characterization data for exosome products

Cold-chain receiving for Southwest shipments

Cryopreserved products ship overnight on dry ice in validated containers and need -80 degree C storage on arrival; lyophilized formats are shelf-stable and are handled per the product insert included with the lot. A practice should have a freezer ready and a staff member assigned to log the lot number when a cryopreserved shipment is due.

Verification and support

Pain management and physical medicine practices should verify their own licensure and scope of practice with the Oklahoma medical board and confirm with their own counsel whether a specific intended use fits their regulatory framework; we do not advise on clinical use, dosing or protocols. Precision Biologics handles NPI verification, account setup and delivery of lot documentation, and can set up a peer-to-peer call focused on paperwork. These products are not FDA approved or licensed for any disease or condition; this page is for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.